Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
58 results about "Blood pressure control" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Intravascular system and method for blood pressure control
InactiveUS20100211131A1Spinal electrodesTransvascular endocardial electrodesNervous systemBlood vessel
An intravascular lead is used to deliver energy for stimulating nervous system targets using energy delivery elements (e.g. electrodes) that are in direct contact with the nervous system targets. The lead may be positioned within the internal jugular vein and the nervous system targets may include the carotid artery / carotid sinus bulb and / or associated baroreceptor afferents, and / or surrounding nervous system targets in the region of the internal jugular vein, such as the carotid sinus nerve and / or associated nerve branches and / or the vagus nerve and / or associated nerve branches. Stimulation energy travels along a conductive bridge that extends from the intravascular lead to the nervous system target, or is relayed from the intravascular lead to another device disposed within or surrounding the target structure.
Owner:INTERVENTIONAL AUTONOMICS
Device and method for regulating blood flow
ActiveUS20060206029A1Reduce the cross-sectional areaReduce the probability of dischargeControl devicesBlood pumpsHeart chamberBlood pressure
A system and method for regulating blood flow rate or blood pressure in a second blood vessel or heart chamber to achieve a balanced flow rate or blood pressure between the second blood vessel or heart chamber and a first blood vessel or heart chamber, wherein the first and the second blood vessels and heart chambers are on opposite sides of the circulatory system. The system comprises a monitor that monitors parameters indicative of a difference between the flow rates or blood pressures of the first and the second blood vessels or heart chambers. A regulator regulates the blood flow rate or blood pressure in at least a portion of the second blood vessel or heart chamber. A controller is configured to receive a signal from the monitor and to determine a difference between the flow rate or blood pressure of the first blood vessel or heart chamber and the flow rate or blood pressure of the second blood vessel or heart chamber. The controller determines a second blood flow rate or blood pressure in the second blood vessel or heart chamber that generates the balanced flow rate or blood pressure between the first and the second blood vessels or heart chambers. The controller then signals the regulator to generate the second determined blood flow rate or blood pressure in the at least portion of the lumen of the second blood vessel or heart chamber.
Owner:TAL YAIR
Use of modified vasoactive intestinal peptides in the treatment of hypertension
ActiveUS20150111829A1Modified receptor binding profileLong persistenceOrganic active ingredientsConnective tissue peptidesHypertension medicationsVasoactive intestinal peptide
The present invention is based on the discovery that a VIP having a binding preference for VPAC2 can provide long-acting blood pressure control synergistically with concomitant anti-hypertensive therapies. Accordingly, methods and compositions useful for the treatment and / or amelioration of hypertension are provided.
Owner:PHASEBIO PHARMA INC
Cookies suitable for hypertension group and making method thereof
InactiveCN103493865AGreat tasteSuppress high blood pressureDough treatmentBakery productsPre treatmentBlood pressure control
The invention relates to cookies suitable for the hypertension group and a making method thereof, and belongs to the field of health-care foods. The cookies comprise the following raw materials, by weight, 90-100 parts of flour, 20-30 parts of highland barley flour, 5-10 parts of salt, 12-18 parts of shortening, 1-2 parts of baking soda, 10-15 parts of folium mori, 10-20 parts of roots of kudzu root, and 5-10 parts of ginkgo leaves. The cookies are beneficial to blood pressure control of the hypertensive, meanwhile, after the raw materials are subjected to a specific preprocessing mode and specific baking processes, the made cookies are better in taste, and the process is simple, cost is low, and the cookies have good market prospects.
Owner:JIANGSU POLYTECHNIC COLLEGE OF AGRI & FORESTRY
Methods and devices for counteracting hypotension
InactiveUS20080269787A1Decreased blood flowReduce impactBronchoscopesLaryngoscopesHypotension shockBlood pressure control
Devices and methods are disclosed to address blood pressure control. More particularly, the present invention relates to correction of transient low blood pressure.
Owner:LAUFER MICHAEL D
Super-portable intelligent dynamic blood pressure detector
InactiveCN103462599ABlood pressure self-managementComfortable to wearEvaluation of blood vesselsSubstation equipmentEmergency medicineBlood pressure monitors
Hidden high blood pressure patients can not be identified by once blood pressure measuring, and the measuring is easily disturbed by emotion and motion states. In ideal blood pressure control, dynamic blood pressure in 24 hours needs to be monitored, the dynamic blood pressure has more advantages compared with the accidentally measured blood pressure, more blood pressure data can be obtained, the change rule of the blood pressure in the whole day can be practically reflected, and the measuring on the dynamic blood pressure has more meanings, and can be used for guiding pharmacy and predicting the seizure of cardiovascular diseases. The current domestic blood pressure monitor in the market is mainly mercurial and electronic blood pressure monitors, which are not convenient for the 24-hour blood pressure monitoring. For overcoming the defects, the invention provides the super-portable intelligent dynamic blood pressure detector, comprising a measuring unit and a smartphone; the measuring unit has no air pipe connection, adopts arm-type integral measuring, has no need of temporary mounting and is suitable for dynamic measuring; the smartphone is connected with the measuring unit by a wireless Bluetooth for transmitting a control command and receiving measuring data.
Owner:NINGBO HI TECH ZONE JINGCHUANG MEDICAL TECHCO LTD
Method and device for counteracting hypotension
InactiveUS20060084835A1Reduce systemic blood pressureBlood flowSurgeryDilatorsLow blood pressuresIntensive care medicine
Devices and methods are disclosed to address blood pressure control. More particularly, the present invention relates to correction of transient low blood pressure.
Owner:LAUFER MICHAEL D
System capable of measuring blood pressure and use method thereof
ActiveCN101564291AEasy to carryEasy to operateNear-field transmissionEvaluation of blood vesselsComputer moduleEmergency medicine
The invention discloses a system capable of measuring blood pressure and a use method thereof. The system comprises a blood pressure measuring control chip, a Bluetooth module and a blood pressure measuring belt which are arranged in a blood pressure measuring device, and a mobile phone blood pressure control unit, a display module, a mobile phone Bluetooth module and a storage module arranged in a main body of a mobile phone; the method for measuring the blood pressure comprises the following steps of: 1) measuring a blood pressure value by the blood pressure measuring control chip; 2) transmitting the blood pressure value to the mobile phone blood pressure control unit in a wireless way; 3) displaying the blood pressure value data; 4) judging whether the blood pressure value is within a safety range, if so, performing step 5), if not, continuing step 6); and 7) storing the blood pressure value data. The invention saves the cost for measuring blood pressure and the time cost, is convenient to measure and beneficial to monitoring the blood pressure condition in real time, and has the functions of monitoring and warning.
Owner:HUAQIN TECH CO LTD
Use of modified vasoactive intestinal peptides in the treatment of hypertension
ActiveUS9561262B2Modified receptor binding profileLong persistenceOrganic active ingredientsConnective tissue peptidesHypertension medicationsVasoactive intestinal peptide
The present invention is based on the discovery that a VIP having a binding preference for VPAC2 can provide long-acting blood pressure control synergistically with concomitant anti-hypertensive therapies. Accordingly, methods and compositions useful for the treatment and / or amelioration of hypertension are provided.
Owner:PHASEBIO PHARMA INC
Ganoderma noodles and manufacturing method thereof
InactiveCN102669551AFull of nutritionImprove immunityDough treatmentClimate change adaptationAging resistanceGluten
The invention provides ganoderma noodles and a manufacturing method thereof. The ganoderma noodles are made from flour, prepared ganoderma powder, edible salt and dietary alkali. The ganoderma noodles are rich in nutrition, can improve the immunity through regular consumption, and have the functions of tumor resistance, aging resistance, blood pressure control, and the like. Compared with the prior art, the ganoderma noodles provided by the invention have no addition of gluten strengthening agents or other additives, however, have very good gluten degree and elasticity; and when the noodles are cooked, the noodles difficultly paste soup and have faint scent.
Owner:张暇
Device for detecting cerebral blood flow regulation function
InactiveCN101889860AStrong self-regulation abilityImprove the safety of useBlood flow measurement devicesDiagnostic recording/measuringPhase differencePrice ratio
The invention discloses a device for detection a cerebral blood flow regulation function, which belongs to the technical field of biomedical engineering. The device comprises a piezoelectric ceramic plate (1), a fixed elastic ribbon (2) of the piezoelectric ceramic plate (1), a trans-cranial Doppler probe module (3), a detection box (5), a light-emitting diode (6) and a phase difference result display LED (7), wherein the piezoelectric ceramic plate (1) is used for measuring pulse waves; the trans-cranial Doppler probe module (3) is used for measuring medium-sized artery blood flow velocity waves; the light-emitting diode (6) is arranged on the detection box (5) and is used for indicating effective characteristic waves; and the piezoelectric ceramic plate (1) and the trans-cranial Doppler probe module (3) synchronously measure signals and are connected with a respiratory frequency band characteristic wave extraction and phase difference detection circuit arranged in the detection box (5) through a connecting wire (4) respectively. The device needs no external artery blood pressure control, has high use safety, uses the piezoelectric ceramic plate to measure pulse pulsation signal waveforms from a wrist directly, and evaluates the cerebral blood flow regulation function according to phase changes of respiration characteristic waves of pulse and the cerebral blood flow, and has the advantages of use safety, simple and convenient operation, quick measuring and processing speed and high performance price ratio.
Owner:YUNNAN UNIV
Compound medicine preparation for treating refractory hypertension
InactiveCN107308181AAvoid careful counting of multiple drug quantitiesAvoid the hassle of dosingOrganic active ingredientsCardiovascular disorderCaptoprilSide effect
The invention discloses a compound medicine preparation for treating refractory hypertension, which is mainly prepared from the following components in parts by weight: 50 to 500 parts of ganoderan, 5 to 10 parts of nifedipine, 12.5 to 50 parts of captopril, 10 to 50 parts of hydrochlorothiazide and 12.5 to 100 parts of atenolol. According to the compound medicine preparation provided by the invention, the ganoderan is compounded with multiple antihypertensive drugs of conventional multiple-treatment to prepare a convenient-to-take compound preparation; the beneficial effects of synergetic antihypertensive effect and mutual side effect relieving / offsetting effect of the ganoderan and the four medicines are realized, the compliance of standardized medicine-taking of refractory hypertension patients is obviously improved, the therapeutic effect of obviously reducing the blood pressure level of the refractory hypertension or even realizing up-to-standard blood pressure control on part of the patients are achieved, and a novel convenient-to-take compound antihypertensive drug is provided for simplifying the drug use of the refractory hypertension patients and effectively reducing the blood pressure level.
Owner:卢广荣
Method and system for analyzing hypertension retinal vessel change characteristic data
PendingCN111222361AEasy to controlImprove complianceMedical imagingCatheterOphthalmologyTherapeutic effect
The invention relates to the technical field of image analysis, health service and data processing, and provides a method for analyzing the hypertension retinal vessel change characteristic data. Themethod includes: obtaining the fundus image of the patient; extracting and identifying the retinal vessel change characteristic data of a fundus image of a patient, wherein retinal vessel change characteristics comprise limitation retinal artery constriction; analyzing and comparing the retinal vessel change characteristic data of the patient in different periods; further obtaining the change condition of the fundus screening characteristic data of the patient; analyzing blood pressure control of the patient in a near period and related prevention and treatment effect conditions of hypertension. A powerful excitation mechanism is provided for enhancing the compliance of basic treatment intervened by the lifestyle of a patient, a user is greatly helped to detect and control the blood pressure consciously and regularly, and the method has important significance in treatment effect evaluation and chronic disease management of hypertension.
Owner:FUZHOU YIYING HEALTH TECH CO LTD
Compound blood pressure lowering capsules for treating metabolic hypertension, preparation method and application thereof
InactiveCN103933216AEasy to controlMetabolism disorderUrinary disorderSalvia miltiorrhizaAdemetionine
Owner:CENT SOUTH UNIV
Devices for counteracting hypotension
InactiveUS7410465B2Decreased blood flowReduce impactSurgeryDilatorsHypotension shockIntensive care medicine
Owner:LAUFER MICHAEL D
Use of modified vasoactive intestinal peptides in the treatment of hypertension
ActiveUS20170072021A1Modified receptor binding profileLong persistenceOrganic active ingredientsConnective tissue peptidesHypertension medicationsVasoactive intestinal peptide
Owner:IMMUNOFORGE CO LTD
Cleviprex fat emulsion concentrated solution, preparation method and application thereof
InactiveCN104706586ANo delaminationImprove liquidityOrganic active ingredientsEmulsion deliverySurgical operationClevidipine
A cleviprex fat emulsion concentrated solution, a preparation method and an application thereof belong to the field of pharmacology and pharmaceutics. According to the invention, the defect that a traditional fat emulsion preparation technology is complex and stability is poor is overcome. The preparation technology provided by the invention is simple; the general physical stirring process is only needed; and no homogenization technology is required. A product prepared in the invention can be sterilized through a 0.22-micron microfiltration membrane; in clinical use, the product can be spontaneously emulsified after diluted by the use of an aqueous solution such as normal saline or a glucose solution, etc. and slightly oscillated; and under optimized conditions, average particle size is about 0.2 micron, and injection fat emulsion characteristics are fully embodied. The product has good fluidity, will not be retained on the wall, is single-phase, transparent and clear in appearance, can undergo clarification detection and will not cause preparation stratification after multigelation. The product is used in blood pressure control during surgical operation and control of acute blood pressure elevation after operation, and also can be used in controlling blood pressure of hypertensives who are not suitable for oral administration or fail in oral administration.
Owner:天津迈迪瑞康生物医药科技有限公司
Breathing adaptation system and method for influencing a breathing parameter
PendingUS20210386319A1Shorten time to sleepQuality improvementUser/patient communication for diagnosticsRespiratory organ evaluationPhysical medicine and rehabilitationControl cell
It is an object of the invention to improve a user's breathing for a specific application (e.g. diagnostic imaging, falling asleep improvement (shortening sleep onset), delivery, tinnitus control therapy, CORD, blood pressure control). This object is achieved by a breathing adaptation system configured for influencing a breathing parameter of a user's breathing pattern in order to meet a goal of decreasing or increasing the influenced breathing parameter to a certain extent in a user specific manner. The breathing adaptation system comprises a sensor, configured for monitoring a current value of the influenced breathing parameter of the user. The breathing adaptation system further comprises a feedback unit configured for providing feedback to the user about a preferred value of the influenced breathing parameter, wherein the preferred value is different from the current value of the influenced breathing parameter (310). The breathing adaptation system further comprises a control unit, comprising program code means for determining the preferred value of the influenced breathing parameter in a user specific manner by means of an intelligent agent, wherein the control unit is implemented such that the intelligent agent is rewarded (330) by means of a reward function after performing the determination of the preferred value (320) of the influenced breathing parameter, wherein the reward function is such that it balances the reward for obtaining the goal and the ability of the user to breathe according to a breathing pattern having the preferred value for the influenced breathing parameter.
Owner:KONINKLJIJKE PHILIPS NV
Hypertension prevention app and web based tools
InactiveUS20160089077A1Reduce consumptionAdequate exercisePhysical therapies and activitiesComputer-assisted medical data acquisitionWeb serviceApplication software
A computer system and method is disclosed as a support structure for patients with hypertension or prehypertension to encourage life style changes leading to dietary control, increase exercise and blood pressure control. The method includes automated messages and responses delivered in real time to encourage appropriate actions by the patient. A diary feature is provided for user input of various relevant parameters, such as foods consumed, exercise activities, body weight, blood pressure, and heart rate. The computer system and method may be implemented on a mobile computing device, such as a smart phone or wearable, a conventional personal computer, or a web service. Most functions will be provided on the mobile device, but some housekeeping and data visualization functions may be limited to the personal computer or web service implementations.
Owner:GERONIMO BUTTON CHRISTINE TINIO +2
Construction method of intractable hypertension prevention and treatment system based on modern communication technology
InactiveCN113707245AEfficient use ofQuickly grasp the blood pressure control situationMedical communicationHealth-index calculationEmergency medicineAcute complication
The invention relates to the technical field of clinical prevention and treatment, in particular to a construction method of a intractable hypertension prevention and treatment system based on a modern communication technology. according to the established prevention and treatment system, limited medical resources can be utilized more efficiently, the blood pressure condition of the refractory hypertension patient can be monitored in real time, and a doctor can quickly master the blood pressure control condition of the patient through real-time monitoring and data analysis. Through data analysis, doctors can carry out targeted follow-up visit on patients with abnormal data or few self-inspection times, psychological counseling, health guidance, medication guidance and the like can be carried out in time, and the healthy life quality of the patients is improved. For patients with sudden acute complications such as cardiovascular and cerebrovascular diseases, doctors can quickly organize experts for consultation through the networking system, make preliminary diagnosis and disease evaluation in time, coordinate and link hospitals through the networking system, open a green channel, and ensure that the patients can be transferred to hospitals meeting treatment conditions in time for diagnosis and treatment.
Owner:YANGZHOU FIRST PEOPLES HOSPITAL
Method for evaluating and treating hypertension
InactiveUS20050090752A1Improve the success rate of treatmentRational drug selectionOrganic active ingredientsDrug and medicationsArteriolar VasoconstrictionTreatment success
The Laragh Method is a novel method useful for evaluating and treating hypertensive patients. The Laragh Method provides a systematic approach for the physician to use volume vasoconstriction information with entry and induced changes in blood pressure and in ambulatory plasma renin levels for the rational selection of treatment tailored to suit each individual hypertensive patient. The Laragh Method provides a systematic and rational approach to drug selection which greatly improves the therapeutic success rate among hypertensive patients and which for the large majority provides long-term blood pressure control with one drug instead of two or two instead of three with each drug rationally targeted to control the renin and / or volume elements in the blood pressure equation.
Owner:LARAGH JOHN H
Compound enzyme with hypotensive function and preparation method thereof
InactiveCN108542957AGreat tasteHigh affinityAlgae medical ingredientsFood ingredient functionsMother cultureSlurry
The invention provides a preparation method for a compound enzyme with a hypotensive function. The preparation method is characterized in that the method comprises the following steps: S1, in parts byweight, washing 37-55 parts of fructus phyllanthi, 11-19 parts of kelp seaweed, 12-24 parts of herba portulacae, 6-14 parts of prickly ash seeds, 12-18 parts of carrots, and 3-7 parts of apples, removing kernels of the fructus phyllanthi, and removing peels of the herba portulacae, crushing to form slurry; S2, preparing a microecological preparation; S3, placing a culture medium obtained in the step S1 and a mother culture obtained in the step S2 in a fermentation tank, and sealing. The compound enzyme can be used as a competitive inhibitor with stronger ACE active region affinity, and combined with Zn<2+> in an ACE active center, the affinity is stronger than the affinity of AngI and bradykinin. The compound enzyme is not easily released from a bonding region, so that ACE is inactivated.The balance of a pressure boosting system and a pressure reducing system to blood pressure control is restored.
Owner:惠州嘉联生物科技开发有限公司
Home management method and system for hemodialysis patients based on informatization technology
PendingCN113261926AFacilitate continuous management between dialysis intervalsSolve the problem of not being able to know in advance whether the patient can drink water on time during their stayEvaluation of blood vesselsOral administration deviceHemodialysisWeight monitoring
The invention relates to a home management method and system for hemodialysis patients based on an informatization technology. The method is characterized in that 1) a management system comprising a patient end, a medical care end and a server is arranged, and the medical care end is wirelessly connected with the patient end through the server or directly connected with the patient end to form a two-way communication loop; 2) the patient end carries out weight measurement reminding, blood pressure measurement reminding, water drinking reminding and medicine taking reminding at regular time so as to enable a patient to carry out weight measurement, blood pressure measurement, quantitative water drinking and quantitative medicine taking at regular time, and if the weight, the blood pressure and the water intake of the patient exceed limits, an alarm is given out; and 3) the medical care terminal monitors the body weight, blood pressure, water intake and medicine taking of the patient and performs health propaganda and education to guide the patient to control the body weight, measure the blood pressure, control the water intake and a medicine taking amount, and the medical care terminal transmits propaganda and education videos or documents to the patient terminal to supervise and urge the patient to conduct learning, observe the learning progress and perform examination reminding. The method and the device have the outstanding substantial characteristic and remarkable progress of capability of monitoring the body weight condition, the water drinking condition and the blood pressure control condition of the patient.
Owner:THE SECOND AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIV
Aorta blood pressure controlled release medicine carrying support and blood pressure control medicine release system
The invention provides an aorta blood pressure controlled release medicine carrying support and a blood pressure control medicine release system, and belongs to the technical field of endovascology. The aorta blood pressure controlled release medicine carrying support comprises a support body, a lining laminating film, a conductive medicine carrying laminating film, a pressure sensitive resistor and a power source; the lining laminating film wraps the inner surface of the support body, and the conductive medicine carrying laminating film wraps the outer surface of the support body; the power source, the pressure sensitive resistor and the support body are connected to form a loop, when pressure borne by the pressure sensitive resistor is larger than a threshold value, the resistance is lowered, micro current exists in the loop, and medicine release is promoted through the conductive medicine carrying laminating film, and micro current can be transmitted to the body surface. The aorta blood pressure controlled release medicine carrying support can perform non-invasive monitoring on aorta blood pressure of a patient, evaluation is performed on the treatment effect of the aorta interlayer, risk early warning is performed, and meanwhile preventive accurate medicine treatment can be performed on the local lesion.
Owner:SHANGHAI CHANGHAI HOSPITAL
A method and apparatus for treatment of drug resistant hypertension associated with impaired left ventricular function and bradycardia using a cardiac pacemaker
PendingUS20220282962A1Lower blood pressureManual control with multiple controlled membersControlling membersCardiac pacemakerBradycardia
The illustrated embodiments include an apparatus having a programmable, implantable pacemaker with a controllable pacing rate; and a blood pressure monitoring device having an output communicated to the pacemaker. The pacemaker selectively and automatically modulates pacing rate in response to monitored blood pressure to reduce hypertensive blood pressure in a patient or treatment for DCHF (HPpEF). The embodiments also include a. method tor operating a pacing device to treat drug resistant hypertension which includes the steps of monitoring blood pressure; and controlling rate modulation in the pacing device in response to the monitored blood pressure to selectively prevent excessive pacing to reduce mean arterial blood pressure fay either inhibiting rate modulation in the pacing device or by changing rate modulation parameters.
Owner:BAROPACE INC
Method and device for identifying hypertensive drug treatment price sensitivity
ActiveCN110134672AAddressing differences in price perceptionAvoid changingMedical data miningDatabase management systemsData setPatient characteristics
The invention discloses a method and device for identifying hypertensive drug treatment price sensitivity. The method comprises the following steps: obtaining patient characteristic data and diagnosing patient characteristic data as primary hypertension through ICD-10, cleaning and desensitizing the characteristic data, and constructing a research queue; establishing a structured analysis data setby combining the research queue with patient follow-up visit data; taking patient cost input and blood pressure control as response targets, analyzing coupling and mapping relations of characteristicparameters of different research queues, and forming a price sensitivity calculation model; and generating a price sensitivity identification axis diagram, calibrating a working scale axis for each patient characteristic parameter, and performing numerical identification and cumulative conversion on the characteristic parameters through the working scale axis to obtain price sensitivity of different patients. The defect that an existing price sensitivity identification method depends on clinical experience is overcome, the price perception difference of multiple drug treatment schemes of a patient can be effectively solved, and reliable reference data is provided for formulating a reasonable drug use scheme for hypertension.
Owner:ZHEJIANG UNIV
Hypertension prevention app and web based tools
InactiveUS20190159720A1Reduce consumptionAdequate exercisePhysical therapies and activitiesNutrition controlWeb serviceFood consumption
A computer system and method is disclosed as a support structure for patients with hypertension or prehypertension to encourage life style changes leading to dietary control, increase exercise and blood pressure control. The method includes automated messages and responses delivered in real time to encourage appropriate actions by the patient. A diary feature is provided for user input of various relevant parameters, such as foods consumed, exercise activities, body weight, blood pressure, and heart rate. The computer system and method may be implemented on a mobile computing device, such as a smart phone or wearable, a conventional personal computer, or a web service. Most functions will be provided on the mobile device, but some housekeeping and data visualization functions may be limited to the personal computer or web service implementations.
Owner:GERONIMO BUTTON CHRISTINE TINIO +2
N-calcium channel knockout animal
InactiveUS7067714B1Maintain steady stateInsensitity to painMaterial analysisAnimal husbandryHuman animalKnockout animal
A non-human animal in which a gene coding for the N-type calcium channel is disrupted to lack functional N-type calcium channel, and a method for screening for a substance having a pharmacological action on blood pressure control, transmission of pain, blood sugar level control and so forth by using the animal.
Owner:EISIA R&D MANAGEMENT CO LTD
Edible flour having blood pressure controlling effect and production method of same
InactiveCN106889423ARetain nutrientsReservation of validityMetabolism disorderFood ingredient functionsPolygonum fagopyrumAngelica Sinensis Root
The invention discloses edible flour having blood pressure controlling effect and a production method of same. The edible flour includes a component A and a component B according to the ratio of A:B = 2 / 1 - 5 / 1. The component A particularly includes: wheat, corn, coix seeds, sorghum, mung beans, sweet potatoes, black sesame, buckwheat, polygonum multiflorum and kudzu roots; the component B particularly includes: chrysanthemum indicum, semen cassiae, bidens bipinnata, cornus officinalis, ilex pubesceus, codonopsis pilosula, hawthorns, Szechwan coptidis rhizome, prunella vulgaris, poria cocos, platycodon grandiflorum, radix bupleuri, pericarpium citri reticulatae, pinellia ternata, licorice roots, tails of angelica sinensis, longan, astragalus membranaceus, honeysuckles, and dendrobe. In the invention, a fine powder is prepared in a cell wall disruption manner, and pure natural traditional Chinese medicines are added, so that the edible flour has abundant nutrients and fine mouth feel and is easy to digest. Medicinal effects of the raw materials are completely remained, so that blood pressure and blood fat of human body are effectively controlled. The edible flour is suitable for people in high blood pressure, high blood glucose and high blood fat.
Owner:李中利
Folk prescription for treating hypertension
The invention discloses a folk prescription for treating hypertension. Each dose of the folk prescription for treating the hypertension is prepared from the following medicinal materials in parts by mass: 20-25g of minuartia, 20-30g of oenanthe stolonifera, 5-10g of folium ginkgo bilobae, 5-10g of cedarwood bark and seeds and 10-15g of tender cedarwood shoots. A processing method of the folk prescription for treating the hypertension comprises the following steps: firstly, juicing oenanthe stolonifera, then adding 1L drinking water, adding cedarwood bark and seeds and tender cedarwood shoots, heating until boiling, then boiling with warm fire for 10 minutes, adding minuartia and oenanthe stolonifera, boiling with warm fire for 15 minutes, filtering, and orally taking decoction; secondly, boiling the original medicinal materials with warm fire for 20 minutes, filtering, and orally taking decoction; thirdly, boiling with warm fire for 30 minutes, filtering, and orally taking decoction. The folk prescription for treating the hypertension has a good curative effect on general hypertension, one treatment course lasts three days, the curative ratio of one treatment course is 81%, the hypertension can be cured in three treatment courses, and the effective rate is 87%. The folk prescription for treating the hypertension has a good effect on blood pressure control, does not cause recurrence and is easy to prepare and low in cost, so that the folk prescription for treating the hypertension is especially applicable to vast rural areas.
Owner:黄平县兴且民族民间中草医药科学发展有限责任公司
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com